APA

Perloff E. S., Mason A. K., Dehal S. S., Blanchard A. P., Morgan L., Ho T., Dandeneau A., Crocker R. M., Chandler C. M., Boily N., Crespi C. L. & Stresser D. M. (20090624). Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design. : Xenobiotica; the fate of foreign compounds in biological systems.

Chicago

Perloff E S, Mason A K, Dehal S S, Blanchard A P, Morgan L, Ho T, Dandeneau A, Crocker R M, Chandler C M, Boily N, Crespi C L and Stresser D M. 20090624. Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design. : Xenobiotica; the fate of foreign compounds in biological systems.

Harvard

Perloff E. S., Mason A. K., Dehal S. S., Blanchard A. P., Morgan L., Ho T., Dandeneau A., Crocker R. M., Chandler C. M., Boily N., Crespi C. L. and Stresser D. M. (20090624). Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design. : Xenobiotica; the fate of foreign compounds in biological systems.

MLA

Perloff E S, Mason A K, Dehal S S, Blanchard A P, Morgan L, Ho T, Dandeneau A, Crocker R M, Chandler C M, Boily N, Crespi C L and Stresser D M. Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design. : Xenobiotica; the fate of foreign compounds in biological systems. 20090624.